Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02895893 · ClinicalTrials.gov registry record · Phase 1
PrEP SMART Phase I Trial
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02895893 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 12 participants.
The verdict
NCT02895893, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of this Phase I study is to conduct a proof-of-concept trial of a contingency management (CM) targeting adherence to oral HIV antiretroviral pre-exposure prophylaxis (PrEP) administered via a smartphone-based medication adherence platform (PrEP SMART, "the app").
Interventions
- BEHAVIORAL PrEP Smart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-05-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02895893
The ClinicalTrials.gov registry entry for NCT02895893 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PrEP Smart is the first listed.
NCT02895893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02895893 about?
NCT02895893 is a clinical study titled "PrEP SMART Phase I Trial". The goal of this Phase I study is to conduct a proof-of-concept trial of a contingency management (CM) targeting adherence to oral HIV antiretroviral pre-exposure prophylaxis (PrEP) administered via a smartphone-based medication adherence platform (PrEP SMART, "the app").
What is the current status of trial NCT02895893?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2016-07. Estimated completion is 2017-05-04.
What interventions are being tested in trial NCT02895893?
The interventions under investigation include: PrEP Smart (BEHAVIORAL).
Who is sponsoring clinical trial NCT02895893?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.